Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02719613
Title Continuing Treatment for Subjects Who Have Participated in a Prior Protocol Investigating Elotuzumab
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | TUR | ROU | POL | ITA | HUN | GRC | GBR | ESP | CAN | BEL | AUS

Facility Status City State Zip Country Details
Local Institution - 0020 Tucson Arizona 85715 United States Details
Local Institution - 0017 Bakersfield California 93309 United States Details
Local Institution - 0022 Fountain Valley California 92708 United States Details
Local Institution - 0016 West Hollywood California 90069 United States Details
Local Institution - 0019 Denver Colorado 80218 United States Details
Local Institution - 0021 Jacksonville Florida 32256 United States Details
Local Institution - 0042 Saint Petersburg Florida 33705 United States Details
Local Institution - 0009 Atlanta Georgia 30322 United States Details
Local Institution - 0003 Indianapolis Indiana 46260 United States Details
Local Institution - 0002 Boston Massachusetts 02215 United States Details
Local Institution - 0008 Saint Louis Missouri 63110 United States Details
Local Institution - 0004 New York New York 10029 United States Details
Local Institution - 0001 Bethlehem Pennsylvania 18015 United States Details
Local Institution - 0018 Dallas Texas 75231 United States Details
Local Institution - 0034 Heidelberg Victoria 3084 Australia Details
Local Institution - 0023 Antwerpen 2060 Belgium Details
Local Institution - 0011 Toronto Ontario M5G 2M9 Canada Details
Local Institution - 0010 Halifax B3H 2Y9 Canada Details
Local Institution - 0035 Athens 11528 Greece Details
Local Institution - 0036 Budapest 1097 Hungary Details
Local Institution - 0015 Ancona 60126 Italy Details
Local Institution - 0012 Firenze 50134 Italy Details
Local Institution - 0013 Genova 16132 Italy Details
Local Institution - 0043 Ravenna 48121 Italy Details
Local Institution - 0044 Terni 05100 Italy Details
Local Institution - 0014 Torino 10126 Italy Details
Local Institution - 0046 Aomori-shi Aomori 0308553 Japan Details
Local Institution - 0047 Shibukawa-shi Gunma 3770280 Japan Details
Local Institution - 0049 Osaka-shi Osaka 5300012 Japan Details
Local Institution - 0048 Koto-ku Tokyo 135-8550 Japan Details
Local Institution - 0050 Chiba 260-8677 Japan Details
Local Institution - 0045 Kasama-shi 3091793 Japan Details
Local Institution - 0027 Chorzow 41-500 Poland Details
Local Institution - 0026 Warszawa 02-106 Poland Details
Local Institution - 0039 Warszawa 02-776 Poland Details
Local Institution - 0028 Bucuresti 030171 Romania Details
Local Institution - 0029 Iasi 700483 Romania Details
Local Institution - 0041 Barcelona 08036 Spain Details
Local Institution - 0030 Toledo 45004 Spain Details
Local Institution - 0031 Cebeci Ankara 06620 Turkey Details
Local Institution - 0032 London EC1A 7BE United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field